At MEDSIR, Rui currently serves as the Business Development Director and Market Expansion, leveraging her extensive experience in business development and oncology networking. She has successfully identified and established funding partnerships for independent clinical studies, particularly in breast and lung cancer. Her role involves collaborating with Key Opinion Leaders and healthcare companies’ leaders, ensuring the strategic development of new molecules for market positioning.  

With a strong background in clinical project management and business development, Rui excels in designing and presenting scientific and operational market-based strategies to optimize clinical drug development. She is committed to driving innovation and advancing clinical research to improve patient outcomes.